Background Combined oral contraceptives (COC s) containing various progestogens could
be associated with differential risks for venous thromboembolism (VTE). Objective To …

Introduction Currently available combined oral contraceptives (COC) reportedly increase the
risk of venous thromboembolism (VTE). We aimed to quantify this risk considering both …

Background Combined oral contraceptive (COC) use has been associated with venous
thrombosis (VT)(ie, deep venous thrombosis and pulmonary embolism). The VT risk has …

Many factors must be considered and discussed with women when initiating a contraceptive
method and the risk of venous thromboembolism (VTE) is one of them. In this review, we …

Objective A systematic review of studies published between January 1995 and April 2010
aimed at determining the effect of combined hormonal contraceptives (CHCs), administered …

Objective To provide a comprehensive overview of the risk of venous thrombosis in women
using different combined oral contraceptives. Design Systematic review and network meta …

CONTEXT: Previous studies have reported that users of the “third-generation” oral
contraceptives (OCs) containing the progestins gestodene and desogestrel have about …

To assess the influence of oral contraceptives (OC) on the risk for venous thromboembolism
(VTE) in young women, a 5-year case-control study including all women 15–44 years old …

Objectives To investigate the factors associated with idiopathic venous thromboembolism in
combined oral contraceptive users and to estimate the crude and age-specific incidence …

The objective of this study was to assess the influence of oral contraceptives (OCs) on the
risk of venous thromboembolism (VTE) in young women. A 5-year case-control study …